MUTYH 相關多腫瘤症（MAP）
K 號：K182784 · 2019-01-18
廣告
器材摘要
MUTYH-Associated Polyposis (MAP) is the device name listed in this FDA 510(k) record. The listed applicant is 23AndMe, Inc.. It received FDA 510(k) clearance on 2019-01-18 under 510(k) number K182784. The device is classified under product code QAZ. It was reviewed by the MG advisory panel. FDA Decision: Substantially Equivalent.
常見問題
What is the MUTYH-Associated Polyposis (MAP)?
MUTYH-Associated Polyposis (MAP) is a medical device that received FDA 510(k) clearance on 2019-01-18. The listed applicant is 23AndMe, Inc.. The 510(k) number is K182784.
When did MUTYH-Associated Polyposis (MAP) receive FDA 510(k) clearance?
MUTYH-Associated Polyposis (MAP) received FDA 510(k) clearance on 2019-01-18, under 510(k) number K182784.
Who is the listed applicant for MUTYH-Associated Polyposis (MAP)?
The FDA 510(k) record lists 23AndMe, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for MUTYH-Associated Polyposis (MAP)?
The FDA product code for MUTYH-Associated Polyposis (MAP) is QAZ.
相關臨床試驗
相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。
其他以 23AndMe, Inc. 為申請人之記錄
相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。
K22359723andMe® Personal Genome Service® (PGS®) Genetic Health Risk Report for BRCA1/BRCA2 (Selected Variants)K22188523andMe Personal Genome Service (PGS) Pharmacogenetic ReportsK21149923andMe PGS Genetic Risk Report for Hereditary Prostate Cancer (HOXB13-Related)K19349223andMe Personal Genome Service (PGS) Pharmacogenetic Reports
相關器械（代碼：QAZ）
相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。
官方來源
在 FDA 資料庫中查看 →資料來源為 FDA Open API。如需最新且權威的資訊，請始終參閱官方記錄。
廣告